Cargando...

In Vivo Effects of Josamycin, Erythromycin, and Placebo Therapy on Nasal Carriage of Staphylococcus aureus

Healthy nasal carriers of Staphylococcus aureus were randomly assigned to one of three treatment regimens: josamycin (1.5 g/day), erythromycin stearate (1.0 g/day), or placebo, each administered orally for 7 days. Quantitative nasal cultures were obtained from each subject at intervals before, durin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Wilson, Samuel Z., Martin, R. Russell, Putman, Margaret
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 1977
Materias:
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC351998/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/324389/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.3.407
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!